These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37084634)

  • 21. Interferon regulatory factor 9 protects against cardiac hypertrophy by targeting myocardin.
    Jiang DS; Luo YX; Zhang R; Zhang XD; Chen HZ; Zhang Y; Chen K; Zhang SM; Fan GC; Liu PP; Liu DP; Li H
    Hypertension; 2014 Jan; 63(1):119-27. PubMed ID: 24144649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The nuclear receptor RORα protects against angiotensin II-induced cardiac hypertrophy and heart failure.
    Beak JY; Kang HS; Huang W; Myers PH; Bowles DE; Jetten AM; Jensen BC
    Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H186-H200. PubMed ID: 30387679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Klotho ameliorated isoproterenol-induced pathological changes in cardiomyocytes via the regulation of oxidative stress.
    Song S; Si LY
    Life Sci; 2015 Aug; 135():118-23. PubMed ID: 26093264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ablation of p21-activated kinase-1 in mice promotes isoproterenol-induced cardiac hypertrophy in association with activation of Erk1/2 and inhibition of protein phosphatase 2A.
    Taglieri DM; Monasky MM; Knezevic I; Sheehan KA; Lei M; Wang X; Chernoff J; Wolska BM; Ke Y; Solaro RJ
    J Mol Cell Cardiol; 2011 Dec; 51(6):988-96. PubMed ID: 21971074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-22 regulates cardiac hypertrophy and remodeling in response to stress.
    Huang ZP; Chen J; Seok HY; Zhang Z; Kataoka M; Hu X; Wang DZ
    Circ Res; 2013 Apr; 112(9):1234-43. PubMed ID: 23524588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of cytochrome P450 1B1 and its associated mid-chain hydroxyeicosatetraenoic acid metabolites in the development of cardiac hypertrophy induced by isoproterenol.
    Maayah ZH; Althurwi HN; El-Sherbeni AA; Abdelhamid G; Siraki AG; El-Kadi AO
    Mol Cell Biochem; 2017 May; 429(1-2):151-165. PubMed ID: 28251434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. G3BP2 is involved in isoproterenol-induced cardiac hypertrophy through activating the NF-κB signaling pathway.
    Hong HQ; Lu J; Fang XL; Zhang YH; Cai Y; Yuan J; Liu PQ; Ye JT
    Acta Pharmacol Sin; 2018 Feb; 39(2):184-194. PubMed ID: 28816235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systems proteomics of cardiac chromatin identifies nucleolin as a regulator of growth and cellular plasticity in cardiomyocytes.
    Monte E; Mouillesseaux K; Chen H; Kimball T; Ren S; Wang Y; Chen JN; Vondriska TM; Franklin S
    Am J Physiol Heart Circ Physiol; 2013 Dec; 305(11):H1624-38. PubMed ID: 24077883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NULP1 Alleviates Cardiac Hypertrophy by Suppressing NFAT3 Transcriptional Activity.
    Zhang X; Lei F; Wang XM; Deng KQ; Ji YX; Zhang Y; Li H; Zhang XD; Lu Z; Zhang P
    J Am Heart Assoc; 2020 Aug; 9(16):e016419. PubMed ID: 32805187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AKAP13 Rho-GEF and PKD-binding domain deficient mice develop normally but have an abnormal response to β-adrenergic-induced cardiac hypertrophy.
    Spindler MJ; Burmeister BT; Huang Y; Hsiao EC; Salomonis N; Scott MJ; Srivastava D; Carnegie GK; Conklin BR
    PLoS One; 2013; 8(4):e62705. PubMed ID: 23658642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early activation of the cardiac CX3CL1/CX3CR1 axis delays β-adrenergic-induced heart failure.
    Flamant M; Mougenot N; Balse E; Le Fèvre L; Atassi F; Gautier EL; Le Goff W; Keck M; Nadaud S; Combadière C; Boissonnas A; Pavoine C
    Sci Rep; 2021 Sep; 11(1):17982. PubMed ID: 34504250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. OGFOD1, a novel modulator of eukaryotic translation initiation factor 2alpha phosphorylation and the cellular response to stress.
    Wehner KA; Schütz S; Sarnow P
    Mol Cell Biol; 2010 Apr; 30(8):2006-16. PubMed ID: 20154146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Global profiling of protein lysine malonylation in mouse cardiac hypertrophy.
    Wu LF; Wang DP; Shen J; Gao LJ; Zhou Y; Liu QH; Cao JM
    J Proteomics; 2022 Aug; 266():104667. PubMed ID: 35788409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CaMKIIδC Drives Early Adaptive Ca
    Ljubojevic-Holzer S; Herren AW; Djalinac N; Voglhuber J; Morotti S; Holzer M; Wood BM; Abdellatif M; Matzer I; Sacherer M; Radulovic S; Wallner M; Ivanov M; Wagner S; Sossalla S; von Lewinski D; Pieske B; Brown JH; Sedej S; Bossuyt J; Bers DM
    Circ Res; 2020 Oct; 127(9):1159-1178. PubMed ID: 32821022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-29a attenuates cardiac hypertrophy through inhibition of PPARδ expression.
    Zhang S; Yin Z; Dai FF; Wang H; Zhou MJ; Yang MH; Zhang SF; Fu ZF; Mei YW; Zang MX; Xue L
    J Cell Physiol; 2019 Aug; 234(8):13252-13262. PubMed ID: 30580435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trim65 attenuates isoproterenol-induced cardiac hypertrophy by promoting autophagy and ameliorating mitochondrial dysfunction via the Jak1/Stat1 signaling pathway.
    Liu H; Zhou Z; Deng H; Tian Z; Wu Z; Liu X; Ren Z; Jiang Z
    Eur J Pharmacol; 2023 Jun; 949():175735. PubMed ID: 37080331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. lncExACT1 and DCHS2 Regulate Physiological and Pathological Cardiac Growth.
    Li H; Trager LE; Liu X; Hastings MH; Xiao C; Guerra J; To S; Li G; Yeri A; Rodosthenous R; Silverman MG; Das S; Ambardekar AV; Bristow MR; González-Rosa JM; Rosenzweig A
    Circulation; 2022 Apr; 145(16):1218-1233. PubMed ID: 35114812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac Overexpression of PDE4B Blunts β-Adrenergic Response and Maladaptive Remodeling in Heart Failure.
    Karam S; Margaria JP; Bourcier A; Mika D; Varin A; Bedioune I; Lindner M; Bouadjel K; Dessillons M; Gaudin F; Lefebvre F; Mateo P; Lechène P; Gomez S; Domergue V; Robert P; Coquard C; Algalarrondo V; Samuel JL; Michel JB; Charpentier F; Ghigo A; Hirsch E; Fischmeister R; Leroy J; Vandecasteele G
    Circulation; 2020 Jul; 142(2):161-174. PubMed ID: 32264695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ClC-3 chloride channel is involved in isoprenaline-induced cardiac hypertrophy.
    Li C; Huang D; Tang J; Chen M; Lu Q; Li H; Zhang M; Xu B; Mao J
    Gene; 2018 Feb; 642():335-342. PubMed ID: 29158167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Canstatin suppresses isoproterenol-induced cardiac hypertrophy through inhibition of calcineurin/nuclear factor of activated T-cells pathway in rats.
    Sugiyama A; Okada M; Yamawaki H
    Eur J Pharmacol; 2020 Mar; 871():172849. PubMed ID: 31843516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.